A Study Of The Effect Of PF-04802540 On Sleep Measures

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy

In brief

The purpose of this study is to determine if PF-04802540 decreases REM sleep.

Key facts

Study ID

NCT00772512

Run by

Taisho Pharmaceutical Co., Ltd.

People needed

13

Starts

2008-11-01

Expected to finish

2009-02-01

Last updated by the study team

2010-03-19

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male and/or female (nonchildbearing potential) subjects between the ages of 18 and 55 years, inclusive
• Body Mass Index (BMI) between 18 to 32 kg/m2, inclusive, and a total body weight >45 kg (99 lbs)
• Non-users of nicotine

You may not qualify if…

• Evidence or history of clinically significant medical illness
• A history of seizures, including childhood febrile seizures
• Any condition possibly affecting drug absorption

Where it is running

• Pfizer Investigational Site — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.